Antibiotics Removal during Continuous Renal Replacement Therapy in Septic Shock Patients: Mixed Modality Versus "Expanded Haemodialysis".

Fiorenza FerrariPaola MillaMarco SartoriChristian ZanzaManfredi TesauroYaroslava LonghitanoAnnalisa De SilvestriChiara AbbruzzeseSilvia De RosaSergio LassolaSara SamoniAlessandra BrendolanMonica ZanellaVittorio ScaravilliGiacomo GrasselliSilvia ArpiccoClaudio Ronco

Published in: Clinical pharmacokinetics (2024)

MCO demonstrated comparable in vivo removal of piperacillin, tazobactam and meropenem to HFM.

Keyphrases

end stage renal disease
septic shock
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
prognostic factors
gram negative
patient reported outcomes